14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      MicroRNAs 24 and 27 suppress allergic inflammation and target a network of regulators of T helper-2 cell-associated cytokine production

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          MicroRNAs (miRNAs) are important regulators of cell fate decisions in immune responses. They act by coordinate repression of multiple target genes, a property that we exploited to uncover regulatory networks that govern T helper-2 (Th2) cells. A functional screen of individual miRNAs in primary T cells uncovered multiple miRNAs that inhibited Th2 cell differentiation. Among these were miR-24 and miR-27, miRNAs coexpressed from two genomic clusters, which each functioned independently to limit interleukin-4 (IL-4) production. Mice lacking both clusters in T cells displayed increased Th2 cell responses and tissue pathology in a mouse model of asthma. Gene expression and pathway analyses placed miR-27 upstream of genes known to regulate Th2 cells. They also identified targets not previously associated with Th2 cell biology which regulated IL-4 production in unbiased functional testing. Thus, elucidating the biological function and target repertoire of miR-24 and miR-27 reveals regulators of Th2 cell biology.

          Related collections

          Author and article information

          Journal
          9432918
          8591
          Immunity
          Immunity
          Immunity
          1074-7613
          1097-4180
          14 January 2016
          2 February 2016
          19 April 2016
          19 April 2017
          : 44
          : 4
          : 821-832
          Affiliations
          [1 ]Department of Pathology, University of California San Francisco, San Francisco, California
          [2 ]Department of Microbiology and Immunology, University of California San Francisco, San Francisco, California
          [3 ]Diabetes Center, University of California San Francisco, San Francisco, California
          [4 ]Department of Medicine, University of California San Francisco, San Francisco, California
          [5 ]Sandler Asthma Basic Research Center, University of California San Francisco, San Francisco California
          Author notes
          [* ]Address correspondence and reprint requests to Dr. K. Mark Ansel, Sandler Asthma Basic Research Center, University of California, San Francisco, 513 Parnassus Avenue, UCSF Box 0414, San Francisco, CA 94143-0414. Mark.Ansel@ 123456ucsf.edu
          [§]

          Current address: Department of Biomedicine, Basel University Hospital and University of Basel, Switzerland.

          Article
          PMC4838571 PMC4838571 4838571 nihpa751437
          10.1016/j.immuni.2016.01.003
          4838571
          26850657
          93237434-1444-4c07-bbd4-27780c68d1ea
          History
          Categories
          Article

          Comments

          Comment on this article